BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19791697)

  • 1. The double burden of disease in developing countries: the Mexican experience.
    Gutiérrez-Delgado C; Guajardo-Barrón V
    Adv Health Econ Health Serv Res; 2009; 21():3-22. PubMed ID: 19791697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current world literature.
    Curr Opin HIV AIDS; 2010 May; 5(3):261-3. PubMed ID: 20539084
    [No Abstract]   [Full Text] [Related]  

  • 3. The double burden of communicable and non-communicable diseases in developing countries.
    Boutayeb A
    Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):191-9. PubMed ID: 16274715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 5. The obligation to provide antiretroviral treatment in HIV prevention trials.
    Lo B; Padian N; Barnes M
    AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double burden of noncommunicable and infectious diseases in developing countries.
    Bygbjerg IC
    Science; 2012 Sep; 337(6101):1499-501. PubMed ID: 22997329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal replacement therapy in the developing world: are we on the right track, or should there be a new paradigm?
    Correa-Rotter R
    J Am Soc Nephrol; 2007 Jun; 18(6):1635-6. PubMed ID: 17494879
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost of AIDS care in Mexico: what are its main individual predictors?
    Aracena B; Gutiérrez JP; Bertozzi SM; Gertler P
    Arch Med Res; 2005; 36(5):560-6. PubMed ID: 16099339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is renal replacement therapy for all possible in developing countries?
    Aviles-Gomez R; Luquin-Arellano VH; Garcia-Garcia G; Ibarra-Hernandez M; Briseño-Renteria G
    Ethn Dis; 2006; 16(2 Suppl 2):S2-70-2. PubMed ID: 16774015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nutritional transition and non-communicable diet-related chronic diseases in developing countries].
    Maire B; Lioret S; Gartner A; Delpeuch F
    Sante; 2002; 12(1):45-55. PubMed ID: 11943638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W; König HH; Schmidt JO; Kalk A
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prioritizing antiretrovirals for second-line therapy in resource-limited countries.
    Naidoo K
    AIDS Clin Care; 2008 May; 20(5):43. PubMed ID: 19230296
    [No Abstract]   [Full Text] [Related]  

  • 15. COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings.
    Hetherington S
    Pediatr Infect Dis J; 2009 Jan; 28(1):41-2. PubMed ID: 19057455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and nutrition transition in developing countries: impact on human health and development.
    Amuna P; Zotor FB
    Proc Nutr Soc; 2008 Feb; 67(1):82-90. PubMed ID: 18234135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Arab Spring: confronting the challenge of non-communicable disease.
    Roberts B; Patel P; Dahab M; McKee M
    J Public Health Policy; 2013 May; 34(2):345-52. PubMed ID: 23536099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A decade of child health research in developing countries].
    Orne-Gliemann J; Perez F; Leroy V; Newell ML; Dabis F
    Sante; 2003; 13(2):69-75. PubMed ID: 14530116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost consideration in renal replacement therapy in Kenya.
    Were AJ; McLigeyo SO
    East Afr Med J; 1995 Jan; 72(1):69-71. PubMed ID: 7781562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing countries face double burden of disease.
    Marshall SJ
    Bull World Health Organ; 2004 Jul; 82(7):556. PubMed ID: 15500291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.